Cytocast

Cytocast: a research-focused and data-driven techbio company, providing a cell simulation platform, that can revolutionize how we treat patients starting from drug discovery and development (Cytocast™ Simulated Cell) to selecting the best treatment option for patients (Cytocast™ Digital Twin). In the future, therapies tailored for each patient will be designed by a computer model of a human cell, harnessing patient-specific whole-cell simulation platform. Committed to developing cutting-edge, patient-specific medical technology solutions that benefit a broad range of clients in the healthcare industry. Dedicated team with unique and diverse skillset: computational biologists, bioinformaticians, developers and researchers shaping the future of medicine. Cytocast is proud to have a strong group of investors committed to revolutionizing drug discovery and the personalized healthcare industry through in silico cell simulation. Our investors include: Creative Accelerator, Bonitás Asset Management, KDT Holding, Fastventures, Futurmed, Zoiros Ventures 🤝We are actively seeking investors who share our vision and are interested in supporting our mission and growth: •.you want to learn more about how Cytocast's technology can benefit your organization •.you're a visionary pharma company, research institution, or healthcare professional eager to advance drug development, let's collaborate and redefine possibilities together! •.you are interested in collaborating with us as a Pilot Study Partner, to validate the effectiveness of our CytocastTM Simulated Cell technology •.you're interested in featuring a story about Cytocast’s mission or conducting an interview with our team members, feel free to reach out. We are open to collaboration and eager to share our insights and expertise